Alkindi Granule
Product Images NDC 71863-111

15 FDA label images from Eton Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Alkindi (NDC 71863-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eton Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 0.5 mg (NDC 71863-109-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 0.5 mg (NDC 71863-109-50)
The image shows the packaging label for Alkindi Sprinkle 0.5 mg oral granules containing hydrocortisone. The label states Rx only and indicates the package contains 50 capsules. It includes administration instructions, a storage statement, and manufacturer details showing Eton Pharmaceuticals, Inc. and Glatt Pharmaceutical Services GmbH & Co. KG. Additional information covers medication guide instructions and a barcode.*
FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 0.5 mg (NDC 71863-109-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 0.5 mg (NDC 71863-109-50)
Label for Alkindi Sprinkle 0.5 mg hydrocortisone oral granules, containing 50 capsules. The label includes storage instructions, a warning not to swallow the capsule due to choking risk, and notes capsules must be opened before administration. Manufactured by Eton Pharmaceuticals, Deer Park, IL.*
FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 1 mg (NDC 71863-110-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 1 mg (NDC 71863-110-50)
Alkindi Sprinkle 1 mg (hydrocortisone) oral granules in a carton label showing 50 capsules per bottle. The label includes warnings that capsules must be opened prior to administration and not swallowed whole due to choking risk. It provides storage instructions for controlled room temperature and manufacturer information, Eton Pharmaceuticals, Inc., Deer Park, IL USA.*
FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 1 mg (NDC 71863-110-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 1 mg (NDC 71863-110-50)
Label for Alkindi Sprinkle (hydrocortisone) oral granules, 1 mg strength, in a capsule form. The label instructs capsules must be opened before administration and not swallowed whole due to choking risk. It includes storage recommendations and cautions, manufactured by Eton Pharmaceuticals, Inc., with a package size of 50 capsules.*
FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 2 mg (NDC 71863-111-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 2 mg (NDC 71863-111-50)
Alkindi Sprinkle 2 mg oral granules packaging label featuring hydrocortisone as the active ingredient. The label includes warnings not to swallow capsules whole, instructions to open capsules prior to administration, and storage information. Manufactured by Eton Pharmaceuticals, Inc., the box indicates a 50-capsule count with a barcode and lot, expiration, and serial number areas for identification.*
FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 2 mg (NDC 71863-111-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 2 mg (NDC 71863-111-50)
The label for Alkindi Sprinkle hydrocortisone oral granules, 2 mg strength, displays dosing instructions and storage guidance. It states this is a prescription product containing 50 capsules, manufactured by Eton Pharmaceuticals, Inc. The label instructs that capsules must be opened prior to administration and not swallowed whole due to choking risk. Storage temperature ranges and discard time after opening are indicated.*
FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 5 mg (NDC 71863-112-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 5 mg (NDC 71863-112-50)
Packaging label for Alkindi Sprinkle 5 mg oral granules (hydrocortisone) from Eton Pharmaceuticals, Inc. The label includes dosage strength, capsule count of 50, administration instructions to open capsules and avoid swallowing whole due to choking risk, storage conditions, and dispensing guidance. It also features the National Drug Code (NDC 71863-112-50) and barcode, along with manufacturer information and space for lot, expiration, and serial numbers.*
FDA Label Image

Alkindi Sprinkle (hydrocortisone) Oral Granules 5 mg (NDC 71863-112-50)

Alkindi Sprinkle (hydrocortisone) Oral Granules 5 mg (NDC 71863-112-50)
Label for Alkindi Sprinkle oral granules containing 5 mg of hydrocortisone per capsule. The label notes the product is Rx only with NDC 71863-112-50 and includes warnings to open capsules prior to administration and not to swallow the capsule due to choking risk. The package contains 50 capsules and is manufactured for Eton Pharmaceuticals, Inc., Deer Park, IL, USA.*
FDA Label Image

Structure (Hydrocortisone Structure)

Structure (Hydrocortisone Structure)
Chemical structure diagram of hydrocortisone, showing its steroid backbone with multiple hydroxyl groups and ketone functional groups. The molecular structure illustrates the arrangement of carbon, hydrogen, and oxygen atoms typical for hydrocortisone.*
FDA Label Image

Image-1 (Image 1)

Image-1 (Image 1)
An instructional illustration showing a hand holding a small capsule-like granule, likely demonstrating the correct way to handle or prepare the Alkindi Sprinkle granule oral dosage form.*
FDA Label Image

Image-2 (Image 2)

Image-2 (Image 2)
An illustration showing a hand holding a small granule, likely demonstrating how to handle or administer oral granules such as Alkindi Sprinkle (hydrocortisone) granules.*
FDA Label Image

Image-3 (Image 3)

Image-3 (Image 3)
An instructional illustration showing a person's hands preparing to empty the contents of a granule packet by tearing it open at the top. The image is likely related to the administration of Alkindi Sprinkle oral granules.*
FDA Label Image

Image-4 (Image 4)

Image-4 (Image 4)
An instructional illustration showing a hand sprinkling granules from a spoon onto a small curved surface, likely depicting the administration method of Alkindi Sprinkle hydrocortisone granules for oral use.*
FDA Label Image

Image-5 (Image 5)

Image-5 (Image 5)
An instructional illustration showing a hand sprinkling granules from a small container or sachet onto a spoon. The image suggests how to administer Alkindi Sprinkle granules orally by transferring them onto a spoon for consumption.*
FDA Label Image

Image-6 (Image 6)

Image-6 (Image 6)
An instructional illustration showing an infant receiving oral medication granules sprinkled onto the tongue using a small spoon or similar applicator. The image emphasizes oral administration suitable for children or infants.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.